Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Mullol, Joaquim" or (type any "bookEditor journalEditor issueEditor" and editor="Mullol, ...

Add to list
- Journal Article
- A1
- open access
Efficacy and safety of dupilumab in patients with uncontrolled severe CRSwNP and a clinical diagnosis of NSAID‐ERD : results from two randomized placebo‐controlled phase 3 trials

Joaquim Mullol, Tanya M. Laidlaw, Claus Bachert (UGent) , Leda P. Mannent, G. Walter Canonica, Joseph K. Han, Jorge F. Maspero, Cesar Picado, Nadia Daizadeh, Benjamin Ortiz, et al.

(2022) ALLERGY. 77(4). p.1231-1244
Add to list
Omalizumab or dupilumab for chronic rhinosinusitis with nasal polyposis Reply

Philippe Gevaert (UGent) , Jonathan Corren, Joaquim Mullol, Joseph Han, Stella E. Lee, Monica Ligueros-Saylan, Kit Wong, Theodore A. Omachi and Claus Bachert (UGent)

(2021) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 147(1). p.413-414
Add to list
Role of biologics in chronic rhinosinusitis with nasal polyposis : state of the art review

Christine Kim, Joseph Han, Tara Wu, Claus Bachert (UGent) , Wytske Fokkens, Peter Hellings (UGent) , Claire Hopkins, Stella Lee, Joaquim Mullol and Jivianne T. Lee

(2021) OTOLARYNGOLOGY-HEAD AND NECK SURGERY. 164(1). p.57-66
Add to list
- Journal Article
- A1
- open access
Data mining of free-text responses : an innovative approach to analyzing patient perspectives on treatment for chronic rhinosinusitis with nasal polyps in a phase IIa proof-of-concept study for dupilumab

Asif H Khan, Adeline Abbe, Bruno Falissard, Paulo Carita, Claus Bachert (UGent) , Joaquim Mullol, Matthew Reaney, Jingdong Chao, Leda P Mannent, Nikhil Amin, et al.

(2021) PATIENT PREFERENCE AND ADHERENCE. 15. p.2577-2586
Add to list
EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics : definitions and management

Claus Bachert (UGent) , Joe K. Han, Martin Wagenmann, Werner Hosemann, Stella E. Lee, Vibeke Backer, Joaquim Mullol, Philippe Gevaert (UGent) , Ludger Klimek, Emanuel Prokopakis, et al.

(2021) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 147(1). p.29-36
Add to list
- Journal Article
- A1
- open access
Dupilumab improves upper and lower airway disease control in chronic rhinosinusitis with nasal polyps and asthma

Tanya M. Laidlaw, Claus Bachert (UGent) , Nikhil Amin, Martin Desrosiers, Peter Hellings (UGent) , Joaquim Mullol, Jorge F. Maspero, Philippe Gevaert (UGent) , Mei Zhang, Xuezhou Mao, et al.

(2021) ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY. 126(5). p.584-592.e1
Add to list
- Journal Article
- A1
- open access
Heterogeneity of the pharmacologic treatment of allergic rhinitis in Europe based on MIDAS and OTCims platforms

Jean Bousquet, Detlef Schröder‐Bernhardi, Claus Bachert (UGent) , G. Walter Canonica, Victoria Cardona, Elisio M. Costa, Wienczyslawa Czarlewski, Philippe Devillier, Joao A. Fonseca, Ludger Klimek, et al.

(2021) CLINICAL AND EXPERIMENTAL ALLERGY. 51(8). p.1033-1045
Add to list
COVID‐19 pandemic : practical considerations on the organization of an allergy clinic : an EAACI/ARIA position paper

Oliver Pfaar, Ludger Klimek, Marek Jutel, Cezmi A. Akdis, Jean Bousquet, Heimo Breiteneder, Sharon Chinthrajah, Zuzana Diamant, Thomas Eiwegger, Wytske J. Fokkens, et al.

(2021) ALLERGY. 76(3). p.648-676
Add to list
International consensus statement on allergy and rhinology : rhinosinusitis 2021

Richard R. Orlandi, Todd T. Kingdom, Timothy L. Smith, Benjamin Bleier, Adam DeConde, Amber U. Luong, David M. Poetker, Zachary Soler, Kevin C. Welch, Sarah K. Wise, et al.

(2021) INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY. 11(3). p.213-739
Add to list
Differentiation of COVID‐19 signs and symptoms from allergic rhinitis and common cold : an ARIA‐EAACI‐GA(2)LEN consensus

Jan Hagemann, Gabrielle L. Onorato, Marek Jutel, Cezmi A. Akdis, Ioana Agache, Torsten Zuberbier, Wienczyslawa Czarlewski, Joaquim Mullol, Anna Bedbrook, Claus Bachert (UGent) , et al.

(2021) ALLERGY. 76(8). p.2354-2366

Academic Bibliography

Efficacy and safety of dupilumab in patients with uncontrolled severe CRSwNP and a clinical diagnosis of NSAID‐ERD : results from two randomized placebo‐controlled phase 3 trials

Omalizumab or dupilumab for chronic rhinosinusitis with nasal polyposis Reply

Role of biologics in chronic rhinosinusitis with nasal polyposis : state of the art review

Data mining of free-text responses : an innovative approach to analyzing patient perspectives on treatment for chronic rhinosinusitis with nasal polyps in a phase IIa proof-of-concept study for dupilumab

EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics : definitions and management

Dupilumab improves upper and lower airway disease control in chronic rhinosinusitis with nasal polyps and asthma

Heterogeneity of the pharmacologic treatment of allergic rhinitis in Europe based on MIDAS and OTCims platforms

COVID‐19 pandemic : practical considerations on the organization of an allergy clinic : an EAACI/ARIA position paper

International consensus statement on allergy and rhinology : rhinosinusitis 2021

Differentiation of COVID‐19 signs and symptoms from allergic rhinitis and common cold : an ARIA‐EAACI‐GA(2)LEN consensus

Contents

Support

Contact